Home › Endocrine Diseases › Florida
Endocrine Diseases clinical trials in Florida
7 studies for Endocrine Diseases are looking for participants at sites in Florida.
Cities in Florida
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
- Ascendis Pharma Investigational Site, Orlando
- Ascendis Pharma Investigational Site, St. Petersburg
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 29, 2026 · NCT07221851A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Nature Coast Clinical Research, Crystal River
- West Coast Eye Institute, Lecanto
- South Broward Research, Miramar
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549Study of BHV-1300 in Graves' Disease
- Site-100, Miami
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jul 31, 2026 · NCT06980649A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Memorial Healthcare System, Hollywood
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
- North Florida/South Georgia Veterans Health System, Gainesville
- Brooks Rehabilitation, Jacksonville
RecruitingPhase 2
Ages 18 and older · Men · Updated May 6, 2025 · NCT04460872Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
- Bascom Palmer Eye Institute, Miami
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Feb 25, 2025 · NCT06112340Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
- Clever Medical Research, Miami
Recruiting
Ages 18 and older · All sexes · Updated Feb 10, 2025 · NCT06681428From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.